Semaglutide dosing and titration schedule, explained

Semaglutide isn't started at its effective dose — it's built up to it in stages, on purpose. Understanding why the schedule is staged the way it is makes the first few months far more predictable, and makes it easier to tell a normal titration side effect from something worth calling your prescriber about.

Why you don't start at the target dose

Semaglutide's most common side effects — nausea, vomiting, and diarrhea — are dose-related, and they're worst when the drug is new to your system. Starting low and increasing gradually gives your gut time to adjust at each step, which is why the pivotal STEP-1 obesity trial dosed participants on a slow escalation schedule over roughly four months before reaching the 2.4 mg maintenance dose, rather than starting patients there directly¹. That staged approach is baked into the FDA label, not a marketing choice by any individual provider⁴.

The general shape of the schedule

The labeled titration for weight-management dosing moves through a series of doses, typically spaced about four weeks apart, starting at a low sub-therapeutic dose and stepping up toward the 2.4 mg weekly maintenance dose used in the trial that established semaglutide's weight-loss effect¹. Your prescriber's exact schedule may differ slightly from a textbook version of this — some people move more slowly through a step if side effects are rough, and clinicians can and do individualize the pace. The point of every version of the schedule is the same: reach the maintenance dose gradually enough that your body has time to adapt.

What a 'step' feels like

It's common to feel mild GI symptoms in the first few days after each dose increase, then have them settle down before the next step. That pattern — a bump after each increase, followed by improvement — is expected and is a large part of why the schedule exists. What isn't expected is symptoms that get progressively worse rather than settling, or severe abdominal pain, persistent vomiting that prevents you from keeping fluids down, or signs of a serious reaction. Our full breakdown of what's common versus what's a red flag is in GLP-1 side effects: what to expect.

If a step is too hard

You don't have to push through a step that's genuinely intolerable. Prescribers can extend a dose longer than the standard four weeks before increasing again, or in some cases step back down temporarily, rather than forcing you up the ladder on a fixed calendar. This is a conversation to have with your prescriber, not a reason to skip doses or self-adjust without telling anyone — an inconsistent, self-managed schedule is harder for a clinician to troubleshoot than a slow, disclosed one.

Injecting it correctly matters too

Technique affects tolerability. Rotating injection sites, using the right needle length, and injecting into the recommended areas all reduce local irritation and help the medication absorb as intended. We cover the mechanics — sites, storage, and technique — in how to inject semaglutide and tirzepatide.

What titration has to do with results

Because the therapeutic dose isn't reached until several months in, meaningful weight loss is typically gradual at first and accelerates as you approach and hold the maintenance dose — one reason early-month comparisons between people on different schedules can be misleading. Our weight-loss timeline walks through what to expect month by month, and if you're also comparing tirzepatide's schedule, see tirzepatide dosing and titration for how that molecule's steps differ. If you've heard about people taking less than the labeled schedule to save money or ease into it more slowly, our honest read on that practice is in GLP-1 microdosing, explained. And if alcohol is part of your routine, it's worth reading GLP-1 and alcohol alongside your titration plan, since slower gut motility from the drug can change how you tolerate it. This is general information about how the schedule works, not a substitute for your prescriber's specific instructions.